Corri Marshall

Corri Marshall currently serves as Co-Founder and Cosmeceutical Director at DermapenWorld, where she leverages her extensive expertise in clinical aesthetics and cosmetic chemistry to drive innovation and excellence in the micro-needling industry. In her pivotal role, Corri oversees the development and operational management of dermaceutical products, ensuring that both domestic and international distributors are equipped with cutting-edge formulations that support optimal treatment outcomes. Her deep understanding of cosmetic dermatology and skin care science has positioned her as a leading authority in the field, enabling her to create targeted skincare solutions that complement Dermapen™ procedures and enhance patient results.

A key aspect of Corri’s work involves spearheading the development of Dp Dermaceuticals™, the world's first skincare line specifically designed for micro-needling treatments. This groundbreaking range supports pre-treatment skin preparation, during-treatment hydration, and post-treatment recovery, ensuring a comprehensive approach to skin rejuvenation. Her expertise in cosmetic formulation and clinical development ensures that these products meet the highest standards of safety, efficacy, and innovation.

Beyond product development, Corri is deeply committed to technical education and training, providing advanced dermaceutical knowledge to practitioners worldwide. Her skills in marketing strategy and communication have been instrumental in establishing DermapenWorld as a global leader in the aesthetic industry. Passionate about making a meaningful difference in patient care and aesthetic outcomes, Corri continues to push the boundaries of cosmeceutical innovation, combining her clinical insights with her entrepreneurial spirit to elevate the standards of micro-needling treatments globally.